Full Text View
Tabular View
Study Results
Related Studies
Study of the Safety and Immunogenicity of an Influenza Vaccine Administered to Healthy Adults
This study has been completed.
Study NCT00264576   Information provided by Novartis

First Received on December 9, 2005.   Last Updated on December 20, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Influenza Disease; Flu
Additional conditions recognized in this trial
Influenza, Human
More general conditions related to this trial
Orthomyxoviridae Infections
Respiratory Tract Diseases
Respiratory Tract Infections
RNA Virus Infections
Virus Diseases
Interventions listed in this trial
Influenza Virus Vaccine
Sponsors listed in this trial
Novartis Vaccines
Novartis Vaccines and Diagnostics (formerly Chiron Vaccines)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services